关注
Helena Barroso
Helena Barroso
Professora Associada, Instituto Universitário Egas Moniz
在 egasmoniz.edu.pt 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics
P Lemey, SL Kosakovsky Pond, AJ Drummond, OG Pybus, B Shapiro, ...
PLoS computational biology 3 (2), e29, 2007
1832007
Beach sand and the potential for infectious disease transmission: observations and recommendations
HM Solo-Gabriele, VJ Harwood, D Kay, RS Fujioka, MJ Sadowsky, ...
Journal of the Marine Biological Association of the United Kingdom 96 (1 …, 2016
1322016
Antimicrobial activity of Terminalia macroptera root
O Silva, A Duarte, M Pimentel, S Viegas, H Barroso, J Machado, I Pires, ...
Journal of ethnopharmacology 57 (3), 203-207, 1997
1061997
Baseline susceptibility of primary HIV-2 to entry inhibitors
P Borrego, R Calado, JM Marcelino, I Bártolo, C Rocha, P Cavaco-Silva, ...
Antiviral therapy 17 (3), 565-570, 2012
632012
Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme
H Barroso, A Freitas-Vieira, LM Lito, JM Cristino, MJ Salgado, HF Neto, ...
Journal of Antimicrobial Chemotherapy 45 (5), 611-616, 2000
582000
Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection
H Barroso, P Borrego, I Bártolo, JM Marcelino, C Família, A Quintas, ...
PloS one 6 (1), e14548, 2011
472011
Evidence for negative selective pressure in HIV-2 evolution in vivo
H Barroso, N Taveira
Infection, Genetics and Evolution 5 (3), 239-246, 2005
422005
An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity
P Borrego, R Calado, JM Marcelino, P Pereira, A Quintas, H Barroso, ...
Aids 27 (7), 1081-1090, 2013
382013
Origin and epidemiological history of HIV-1 CRF14_BG
I Bartolo, AB Abecasis, P Borrego, H Barroso, F McCutchan, P Gomes, ...
PLoS One 6 (9), e24130, 2011
372011
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism
JM Marcelino, P Borrego, C Nilsson, C Família, H Barroso, F Maltez, ...
Aids 26 (18), 2275-2284, 2012
352012
Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy
JM Marcelino, P Borrego, C Rocha, H Barroso, A Quintas, C Novo, ...
Journal of virology 84 (23), 12429-12436, 2010
352010
Inhibitory activity of a green and black tea blend on Streptococcus mutans
H Barroso, R Ramalhete, A Domingues, S Maci
Journal of oral microbiology 10 (1), 1481322, 2018
332018
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients
P Borrego, JM Marcelino, C Rocha, M Doroana, F Antunes, F Maltez, ...
Retrovirology 5, 1-12, 2008
312008
HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients
H Skar, P Borrego, TC Wallstrom, M Mild, JM Marcelino, H Barroso, ...
Journal of virology 84 (14), 7412-7415, 2010
302010
Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and …
JM Marcelino, H Barroso, F Gonçalves, SM Silva, C Novo, P Gomes, ...
Journal of clinical microbiology 44 (2), 607-611, 2006
282006
Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
C Rocha, R Calado, P Borrego, JM Marcelino, I Bártolo, L Rosado, ...
Retrovirology 10, 1-14, 2013
252013
Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression
JM Marcelino, C Nilsson, H Barroso, P Gomes, P Borrego, F Maltez, ...
Aids 22 (17), 2257-2265, 2008
212008
Molecular Characterization of a Ceftazidime-Resistant Morganella morganii Isolate Producing a TEM-10 β-Lactamase
H Barroso, A Freitas-Vieira, A Duarte
Antimicrobial agents and chemotherapy 43 (2), 434-435, 1999
201999
Prevalência da cárie dentária e presença de bactérias cariogénicas no dorso lingual–Estudo seccional cruzado
J Galrão, L Proença, H Barroso
Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia …, 2012
192012
High hydrostatic pressure as sterilization method for drug-loaded intraocular lenses
A Topete, CA Pinto, H Barroso, JA Saraiva, I Barahona, B Saramago, ...
ACS Biomaterials Science & Engineering 6 (7), 4051-4061, 2020
172020
系统目前无法执行此操作,请稍后再试。
文章 1–20